Trocars and Access Devices Market

Trocars And Access Device Market By Product Type Single-Use Trocars, Reusable Trocars, And Responsible Trocars), Tip-Type (Bladeless Trocars, Optical Trocars, Blunt Trocars, Bladed Trocars, And Others), End-User (Hospitals, Ambulatory Surgical Centers) And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) are expected to grow at a steady CAGR forecast till 2030 owing to the growing adoption of minimally invasive surgical procedures, increase in incidence of cancer such as gallbladder cancer, colorectal cancer, uterus cancer, and technological advancement with increase in number of product launches across the globe. 

The global trocars and access device market is estimated to grow at a CAGR of 5.13% during the forecast period from 2024 to 2030. The demand for trocars and access devices is primarily being boosted by the growing adoption of minimally invasive surgeries such as laparoscopic surgeries, endoscopic surgeries robotic-assisted surgeries, and others. Furthermore, the market for trocars and access devices is boosted by the rising incidence of cancers such as gallbladder cancer, colorectal cancer, uterus cancer, and others. Additionally, the trocars and access device market is anticipated to grow on account of a large number of product launches with technological advancement. Thus, these are some of the key drivers that are responsible for contributing to the positive growth of the trocars and access device market during the forecast period from 2024-2030.

Trocars And Access Device Market Dynamics:

According to the latest data provided by GLOBOCAN (2024), in 2022 the estimated number of new cases of gallbladder cancer globally was 122,000, while colon cancer accounted for 1.14 million cases and cervix and corpus uteri cancer for 1.08 million cases. Projections suggest that by 2030, these numbers are expected to rise significantly, with an increase of 210,000 new cases for gallbladder cancer, 1.41 million for colon cancer, and 1.26 million for cervix and corpus uteri cancer. This anticipated surge in cancer cases is likely to drive the demand for trocars, as they are essential instruments used in minimally invasive surgical procedures for the diagnosis and treatment of various cancers. Additionally, as per the latest report provided by Global Burden of Disease, in 2019 there were approximately 193 million cases of gallbladder and biliary disease globally. Thus, the population with gallbladder cancer, colon cancer, and uterine cancer may undergo laparoscopic surgeries for various reasons, including diagnostic staging, tumor resection, and palliative interventions thereby boosting the market of trocars as these instruments are essential for creating access ports during laparoscopic procedures. 

According to the data provided by the World Health Organization (WHO) (2024), in 2022 globally out of 8 people, 1 person was living with obesity. Furthermore, as per the same source in 2022, approximately 2.5 billion people were overweight and out of these 890 million people were living with obesity worldwide. Thus, the global rise in the population of obesity will increase the chances of adoption of safe weight loss surgery or bariatric laparoscopic surgery which will further raise the demand for trocars and access devices.

Advancements in technology have played a major role in improving the overall market trends of trocars and access devices. For instance, in 2021, DORC introduced the EVA AVETA™ trocar cannula system, a fully redesigned trocars cannula system with advanced features like push-fit infusion connection and plus a unique laser-etched retention feature. Thus, this innovative launch is poised to fuel substantial growth within the market of trocars. 

However, the risk of injury and infection and its stringent regulatory concerns may hinder the market demand of trocars and access device.

Trocars And Access Device Market Segment Analysis:

Trocars and Access Device Market by Product Type (Single Use Trocars, Reusable Trocars, and Reposable Trocars), Tip-Type (Bladeless Trocars, Optical Trocars, Blunt Trocars, Bladed Trocars, and Others), End-User (Hospitals, Ambulatory Surgical Centers) and Geography (North America, Europe, Asia-Pacific, and Rest of the World). 

In the product segment of the trocars and access device market, the single-use trocars are estimated to mass a significant revenue share in the trocars and access device market in 2023. This can be attributed to the various advantages and applications provided by the single use trocars. Disposable trocars eliminate the risk of cross-contamination between patients since they are used only once and then discarded. This helps prevent the transmission of infectious pathogens and reduces the incidence of healthcare-associated infections. Since disposable trocars are used only once, they maintain consistent sharpness and performance for each procedure. Disposable trocars are convenient to use and require minimal preparation. Healthcare providers can simply unpack a sterile trocar from its packaging and immediately proceed with the procedure, without the need for additional setup or instrument processing.

For instance, in 2021, Espiner introduced the Espiner Trocar, a disposable laparoscopic trocar designed for precision and control providing safe and straightforward access to the peritoneal cavity. Thus, such strategic initiatives is poised to fuel substantial growth within the market of trocars. Hence, all the factors and product development are promoting the overall market growth of trocars and access devices during the forecast period.

North America Is Expected To Dominate The Overall Trocars And Access Device Market:

North America is expected to account for the highest proportion of the Trocars and access device market in 2023, out of all regions. This domination is due to the growing adoption of minimally invasive surgical procedures in the region. Moreover, the trocars and access device market is anticipated to grow on account of growing obese population, product approval and launches, increase in cancer cases, and an advanced healthcare system in the region in North America.

According to the data provided by the GLOBOCAN (2024), in 2022 the overall estimated new cases of gallbladder cancer, colorectal cancer, and uterus cancer was 279,000 in North America. Additionally, according to the American Society for Metabolic and Bariatric Surgery 2021 data, a total of 256,000 bariatric surgeries were performed in the US in the year 2019. Therefore, escalating obese people opting for weight loss surgery will further raise the demand for laparoscopic surgery thereby boosting the market of trocars and access devices.

For instance, in 2022, CONMED Corporation marked the launch of Edge™ Laparoscopic Trocars, a new line of trocars boasting advanced blade technology engineered to optimize access efficiency and safety in the realm of minimally invasive surgeries. Thus, the recent launches in trocars and access devices are also playing a major role in driving the overall market of trocars and access devices in North America.

Therefore, the improving healthcare facilities in the region, rise in surgeries, increase in cancer cases, the growing obese population, product approval and launches, and increase in patient awareness regarding the benefits of minimally invasive surgery procedures, and others are likely to spur the trocars and access devices in the region.

Trocars And Access Device Market Key Players:

Some of the key market players operating in the Trocars and access device include B. Braun, Medtronic, Johnson & Johnson, Karl Storz, Olympus, Applied Medical Resources Corporation, CONMED Corporation., Teleflex Incorporated., Stryker, Smith+Nephew., Richard Wolf GmbH., CooperSurgical, Fortimedix Surgical, Molnlycke Health Care, Purple Surgical, Silex Medical, LLC, BNR Co., Ltd., Cousin Biotech, Ethicon, Inc., Maxer Endoscopy, and others.

Recent Developmental Activities In The Trocars And Access Device Market:

• In June 2023, Xpan, a leading surgical instrument firm based in Canada, received approval of 510(k) from the U.S. Food and Drug Administration for its Universal Trocars System, is designed to minimize tissue damage and enhance access during laparoscopic surgery.
• In March 2023, Peters Surgical acquired Vectac, a France-based company, as part of its strategic expansion initiatives. This acquisition is poised to bolster Peters Surgical's product portfolio with extended product range encompassing trocars, scissors, and endoscopic forceps, particularly tailored for laparoscopic surgery to cater to the evolving needs of gynecology, urology, and visceral surgery fields.  

Key Takeaways From The Trocars And Access Device Market Report Study

• Market size analysis for current Trocars and access device Market size (2023), and market forecast for 6 years (2024-2030).
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years.
• Key companies dominating the global Trocars and access device market.
• Various opportunities available for the other competitors in the Trocars and access device Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Trocars and access device market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Trocars and access device market growth in the coming future?

Target Audience Who Can Be Benefited From This Trocars And Access Device Market Report Study

• Trocars and access device product providers.
• Research organizations and consulting companies. 
• Trocars and access device-related organizations, associations, forums, and other alliances.
• Government and corporate offices.
• Start-up companies, venture capitalists, and private equity firms.
• Distributors and Traders dealing in Trocars and access device Filters.
• Various end-users who want to know more about the Trocars and access device Market and the latest technological developments in the Trocars and access device Market.

Frequently Asked Questions For The Trocars And Access Device Market:

1. What are trocars and access devices?

Trocars and access devices are instruments used in minimally invasive surgery (MIS) procedures, also known as laparoscopic surgery or keyhole surgery. These tools are designed to create and maintain access ports in the patient's body for the insertion of surgical instruments and the passage of gases or fluids during the procedure. They play a crucial role in facilitating the surgeon's ability to perform surgery through small incisions, reducing trauma, pain, and recovery time for the patient compared to traditional open surgery. 

2. What is the market for trocars and access devices?

The global trocars and access device market is estimated to grow at a CAGR of 5.13% during the forecast period from 2024 to 2030.

3. What are the drivers for the global trocars and access device market?

The demand for trocars and access devices is primarily being boosted by the growing adoption of minimally invasive surgeries such as laparoscopic surgeries, endoscopic surgeries, robotic-assisted surgeries, and others. Furthermore, the market for trocars and access devices is boosted by the rising incidence of cancers such as gallbladder cancer, colorectal cancer, uterus cancer, and others. Additionally, the trocars and access device market is anticipated to grow on account of a large number of product launches with technological advancement. Thus, these are some of the major drivers that are responsible for contributing to the positive growth of the trocars and access device market during the forecast period from 2024-2030.

4. Who are the key players operating in the global trocars and access device market?

Some of the key market players operating in the Trocars and access device include B. Braun, Medtronic, Johnson & Johnson, Karl Storz, Olympus Corporation, Applied Medical Resources Corporation, CONMED Corporation., Teleflex Incorporated., Stryker, Smith+Nephew., Richard Wolf GmbH., CooperSurgical, Fortimedix Surgical, Molnlycke Health Care, Purple Surgical, Silex Medical, LLC, BNR Co., Ltd., Cousin Biotech, Ethicon, Inc., Maxer Endoscopy, and others.

5. Which region has the highest share in the global trocars and access device market?

North America is expected to account for the highest proportion of the Trocars and access device market in 2023, out of all regions. This domination is due to the growing adoption of minimally invasive surgical procedures in the region. Moreover, the trocars and access device market is anticipated to grow on account of growing obese population, product approval and launches, increase in cancer cases, and an advanced healthcare system in the region in North America.